Sitala Bio
PrivateLast Round
Strategic
Aug 1, 2025
Est. Valuation
$50M
Total Funding Raised
$5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sitala Bio is a biotechnology company that develops anti-inflammatory medicines for the treatment of neurodegenerative and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sitala Bio Comparables
Compare Sitala Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Brenig Therapeutics | 82% | |
| NodThera | 81% | |
| Olatec Therapeutics | 80% |
For institutional investors. Book with your work email.
Sitala Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Aug 1, 2025 |
For institutional investors. Book with your work email.
Sitala Bio Investors
Notable investors and investment history
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 147% MoM, reaching 1.7K.
- Apr 17, 2026
Monthly visitors increased 92% MoM.
For institutional investors. Book with your work email.
Sitala Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sitala Bio's valuation, stock price, and market status.
Is Sitala Bio a public or private company?
Sitala Bio is a private company.
What is the current stock price of Sitala Bio?
Sitala Bio is a private company, so its shares have no public market price. Caplight tracks Sitala Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sitala Bio worth (valuation)?
Sitala Bio's valuation is estimated at $50.0M based on funding round data.
Can I buy Sitala Bio stock?
Sitala Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sitala Bio's last funding round?
Sitala Bio's most recent funding round was Strategic on August 1, 2025.
Who are the main investors in Sitala Bio?
Key investors in Sitala Bio include Forbion, OrbiMed.
Will Sitala Bio IPO soon?
No public IPO plans have been announced for Sitala Bio.
How can I track Sitala Bio secondary market activity?
Caplight tracks bids, offers, and trades in Sitala Bio's shares on secondary markets.